Bioinformatics analysis identifies potential hub genes and crucial pathways in the pathogenesis of asthenozoospermia

Abstract

Background Asthenozoospermia is a troublesome disease experienced by men in their reproductive years, but its exact etiology remains unclear. To address this problem, this study aims to identify the hub genes and crucial pathways in asthenozoospermia. Methods We screened two Gene Expression Omnibus (GEO) datasets (GSE92578 and GSE22331) to extract the differentially expressed genes (DEGs) between normozoospermic and asthenozoospermic men using the “Limma” package. Gene enrichment analyses of the DEGs were conducted using the “clusterProfiler” R package. The protein-protein interaction (PPI) network was then established using the STRING database. A miRNA-transcription factor-gene network was constructed based on the predicted results of hub genes using the RegNetwork database. The expression of four hub genes in asthenozoospermia and normal samples were verified using quantitative real-time reverse transcription-polymerase chain reaction (qRT-PCR) and western blotting. Results We identified 271 DEGs, which included 218 upregulated and 53 downregulated in two asthenozoospermia datasets. These DEGs were observed to be markedly enriched in pathways with cell growth and embryonic organ development, phospholipase D signaling pathway, cGMP-PKG signaling pathway, and Wnt signaling pathway. The most significant genes were identified, including COPS7A, CUL3, KLHL7, NEDD4. We then constructed regulatory networks of these genes, miRNAs, and transcription factors. Finally, we found that the COPS7A was significantly upregulated in patients with asthenozoospermia, but CUL3, KLHL7 and NEDD4 were significantly downregulated compared with normal samples. Conclusion We applied bioinformatics methods to analyze the DEGs of asthenozoospermia based on the GEO database and identified the novel crucial genes and pathways in this disease. Our findings may provide novel insights into asthenozoospermia and identify new clues for the potential treatment of this disease.

Elucidation of the mechanism of action of ailanthone in the treatment of colorectal cancer: integration of network pharmacology, bioinformatics analysis and experimental validation

“…Network pharmacology is employed to identify candidate targets and elucidate bioactive compound functions in disease treatment and bioinformatics analysis is instrumental in investigating complicated gene–disease relationships and regulatory mechanisms ( Wang et al, 2022 ). These approaches have deepened our understanding regarding the action mechanisms of drugs ( Zou et al, 2022 ), successfully revealing the multitargeted pharmacological roles of several compounds including Fumaria indica and the Phellodendron–Anemarrhena drug pair in hepatocellular carcinoma treatment ( Batool et al, 2022 ; Ruan et al, 2022 ). Similarly, Xia et al used bioinformatics and network pharmacology to determine the inhibition mechanism of luteolin on the proliferation and migration of glioblastoma cells through the key targets BIRC5 and CCNB1, which impacted the prognosis of patients with glioblastoma ( Xia Z. et al, 2022b ).…”

Identification of potential biomarkers and pathways for asthenozoospermia by bioinformatics analysis and experiments

“…Our previous research has provided initial insights into the dysregulated competitive endogenous RNA (ceRNA) network in asthenozoospermia, highlighting the potential involvement of exosomal lncRNAs in the pathogenesis of this condition ( 13 ). Although previous bioinformatics analyses have identified potential key lncRNAs, miRNAs, hub genes, and crucial pathways associated with asthenozoospermia ( 14 – 16 ), there are still many unexplored molecular mechanisms and potential biomarkers that related to asthenozoospermia need to be elucidated.…”

Unveiling Molecular Markers and Prediction of Stomach Cancer from Transcriptomic Profile: A Comprehensive Study of Feature Mining and Learning-based Algorithm

“…The feature selection techniques are categorized into Unsupervised, Supervised, and Semisupervised based on the input dataset 11 . Within supervised feature selection, there are three main fashions 12 : filter, wrapper, and embedded. Finding an adequate feature set and enhancing the performance of the classification model's interpretability are the primary objectives of all techniques.…”

“…However, there is a lack of studies focusing on identifying the best feature selection techniques for bulk RNA-Seq data to identify potential therapeutic molecular markers or targets and gain molecular insights into cancer diagnosis and treatment. Even though, current existing studies identified disease associated features or genes on traditional Bioinformatics based interpretation 12,13,14 .…”